Karin Tunblad
Huddinge, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 23, 2026
A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 23, 2026
Therapeutic subtypes of knee osteoarthritis: differential treatment effects among predicted endotypes in past clinical trials.
Journal: Arthritis research & therapy
Published: December 29, 2025
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases.
Journal: Journal of hepatocellular carcinoma
Published: June 06, 2024
The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis.
Journal: Journal of translational medicine
Published: October 12, 2017
Selective Cathepsin S Inhibition with MIV-247 Attenuates Mechanical Allodynia and Enhances the Antiallodynic Effects of Gabapentin and Pregabalin in a Mouse Model of Neuropathic Pain.
Journal: The Journal of pharmacology and experimental therapeutics
Published: February 19, 2016
Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 12, 2014
Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
Journal: The FEBS journal
Published: May 23, 2014
Population PKPD modeling of BACE1 inhibitor-induced reduction in Aβ levels in vivo and correlation to in vitro potency in primary cortical neurons from mouse and guinea pig.
Journal: Pharmaceutical research
Published: May 20, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026